Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 5 | 2018 | 130 | 1.430 |
Why?
|
| Genetic Counseling | 2 | 2017 | 44 | 0.910 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2024 | 533 | 0.830 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 44 | 0.690 |
Why?
|
| Genetic Services | 1 | 2017 | 4 | 0.530 |
Why?
|
| Glycogen Storage Disease Type V | 1 | 2017 | 3 | 0.520 |
Why?
|
| Neonatal Screening | 1 | 2015 | 49 | 0.450 |
Why?
|
| Patient Care Team | 1 | 2017 | 278 | 0.440 |
Why?
|
| Home Care Services | 1 | 2015 | 72 | 0.430 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2014 | 9 | 0.430 |
Why?
|
| Autistic Disorder | 2 | 2024 | 126 | 0.430 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2014 | 14 | 0.420 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2014 | 11 | 0.420 |
Why?
|
| Microarray Analysis | 1 | 2014 | 69 | 0.420 |
Why?
|
| Epilepsy, Absence | 1 | 2014 | 11 | 0.420 |
Why?
|
| Corneal Diseases | 1 | 2014 | 16 | 0.420 |
Why?
|
| Cornea | 1 | 2014 | 54 | 0.410 |
Why?
|
| Joint Diseases | 1 | 2014 | 40 | 0.410 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 141 | 0.410 |
Why?
|
| Patients | 1 | 2014 | 52 | 0.400 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 60 | 0.400 |
Why?
|
| Cognition Disorders | 1 | 2014 | 199 | 0.380 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 166 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 193 | 0.370 |
Why?
|
| Primary Health Care | 1 | 2015 | 404 | 0.350 |
Why?
|
| Telemedicine | 1 | 2017 | 512 | 0.330 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 38 | 0.330 |
Why?
|
| Blindness | 1 | 2024 | 33 | 0.220 |
Why?
|
| Humans | 15 | 2024 | 53230 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2024 | 333 | 0.180 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 625 | 0.170 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 8 | 0.170 |
Why?
|
| Retinal Dystrophies | 1 | 2021 | 6 | 0.170 |
Why?
|
| Eye Proteins | 1 | 2021 | 17 | 0.170 |
Why?
|
| Female | 9 | 2024 | 28782 | 0.160 |
Why?
|
| Genotype | 3 | 2024 | 563 | 0.150 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 28 | 0.150 |
Why?
|
| Growth Disorders | 1 | 2019 | 67 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 171 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 148 | 0.140 |
Why?
|
| Male | 8 | 2024 | 27435 | 0.140 |
Why?
|
| Coloboma | 1 | 2017 | 1 | 0.130 |
Why?
|
| Alu Elements | 1 | 2017 | 7 | 0.130 |
Why?
|
| Ichthyosis | 1 | 2017 | 4 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2913 | 0.130 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2017 | 6 | 0.130 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2017 | 14 | 0.130 |
Why?
|
| Models, Organizational | 1 | 2017 | 58 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2017 | 69 | 0.130 |
Why?
|
| Physician's Role | 1 | 2017 | 49 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2018 | 223 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2017 | 109 | 0.130 |
Why?
|
| Hearing Loss, Conductive | 1 | 2017 | 55 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 61 | 0.120 |
Why?
|
| Child | 4 | 2024 | 7379 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2017 | 129 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 292 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 74 | 0.110 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2014 | 10 | 0.110 |
Why?
|
| Anterior Eye Segment | 1 | 2014 | 5 | 0.110 |
Why?
|
| Galactosyltransferases | 1 | 2014 | 8 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 58 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2014 | 193 | 0.100 |
Why?
|
| Adolescent | 3 | 2024 | 6907 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 934 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 477 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 412 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2019 | 1748 | 0.090 |
Why?
|
| Genetic Association Studies | 2 | 2024 | 124 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2014 | 501 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 803 | 0.070 |
Why?
|
| Alleles | 2 | 2018 | 277 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 14534 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 3494 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2010 | 1557 | 0.060 |
Why?
|
| Bone Diseases, Developmental | 1 | 2024 | 17 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2024 | 110 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2024 | 4162 | 0.050 |
Why?
|
| Middle Aged | 2 | 2018 | 13419 | 0.050 |
Why?
|
| Electroretinography | 1 | 2021 | 18 | 0.040 |
Why?
|
| Ophthalmoscopy | 1 | 2021 | 17 | 0.040 |
Why?
|
| Exons | 1 | 2021 | 100 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 114 | 0.040 |
Why?
|
| Aged | 1 | 2014 | 10429 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 180 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 19 | 0.040 |
Why?
|
| Facies | 1 | 2019 | 36 | 0.040 |
Why?
|
| Young Adult | 2 | 2019 | 4511 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 533 | 0.030 |
Why?
|
| Introns | 1 | 2017 | 51 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2018 | 164 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2019 | 324 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 1204 | 0.030 |
Why?
|
| Infant | 1 | 2024 | 3805 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 505 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1212 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1368 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 6819 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1583 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 4017 | 0.020 |
Why?
|